CEBEDEX
DEAD

Serial Number

85959221

Owner

GW Pharma Limited

Attorney

Michelle L. Visser

Filing Date

Jun 13, 2013

Add to watchlist:

No watchlists yet
View on USPTO

CEBEDEX Trademark

Serial Number: 85959221

CEBEDEX is a trademark filed by GW Pharma Limited on June 13, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Trademark Details

Filing Date

June 13, 2013

Registration Date

Not Registered

Published for Opposition

May 13, 2014

Goods & Services

Pharmaceutical and veterinary preparations and substances for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohns disease, alzheimers, bone disorders, drug, alcohol and nicotine abuse; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical and veterinary preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, bladder disfunction, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, multiple sclerosis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, alzheimers, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse; herb teas for medicinal purposes

Filing History

ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Sep 21, 2015 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Sep 21, 2015 ABN4
OPPOSITION TERMINATED NO. 999999
Sep 21, 2015 OP.T
OPPOSITION SUSTAINED NO. 999999
Sep 21, 2015 OP.S
POST PUBLICATION AMENDMENT - ENTERED
Nov 13, 2014 CHPB
ASSIGNED TO PETITION STAFF
Nov 12, 2014 APET
OPPOSITION INSTITUTED NO. 999999
Nov 10, 2014 OP.I
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 6, 2014 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 11, 2014 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 13, 2014 NPUB
PUBLISHED FOR OPPOSITION
May 13, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 23, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 10, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2014 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2014 CRFA
ASSIGNED TO LIE
Mar 31, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 19, 2013 GNRN
NON-FINAL ACTION E-MAILED
Sep 19, 2013 GNRT
NON-FINAL ACTION WRITTEN
Sep 19, 2013 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 21, 2013 NWOS
NEW APPLICATION ENTERED
Jun 17, 2013 NWAP